Alpha-fetoprotein (AFP) is widely used as a serological marker in the diagn
osis of hepatocellular carcinoma (HCC) and non-seminomatous germ cell tumou
rs (NSGCT). By application of isoelectric focusing (IEF) disease-specific A
FP isoforms can be identified Three major bands are apparent: + I (associat
ed with 'benign' liver disease), + II (associated with HCC) and +[I( (assoc
iated with NSGCT). Recently we have characterized the predominant glycans o
f human serum AFP and now report the application of these findings and elec
trospray ionization-mass spectrometry (ESI-MS) to the determination of the
glycan composition of the isoforms present in the sera of 12 patients with
MCC and of one patient with NSGCT. ESI-MS allowed simultaneous identificati
on of various AFP glycoforms in purified serum AFP. Seven glycoforms were i
dentified, but with different abundance in the sera of the HCC patients, wh
ereas six glycoforms were identified in the serum from the NSGCT patient. T
he glycan structures of these glycoforms were deduced from their observed m
asses. AFP glycoforms carrying a single biantennary complex-type N-glycan a
ppeared as the predominant glycoforms, whereas those carrying both N-glycan
and O-glycan appeared as minor glycoforms. Correlation between the abundan
ce of the AFP glycoforms and the IEF band intensity suggested that differen
t degrees in sialylation cause the formation of isoforms. This contention w
as subsequently supported by the ESI-MS and kinetic in vitro desialylation
studies on purified Bands + I and + II AFPs. Our findings indicate that HCC
-associated isoforms (Band + [I) represent a group of glycoproteins whose c
arbohydrate structures are ail characterized by being mono-sialylated, wher
eas those associated with benign liver disease and NSGCT are di- and a-sial
o species, respectively. Knowledge of the structure of the tumour-specific
isoforms should form an important basis for clinically useful assays. (C) 2
000 Cancer Research Campaign.